Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
CEO: Kirk L. Perry. Company website
Kenvue Inc. (KVUE) trades at $17.81, down 0.34% on the day, as of Sep 20, 2026 13:47 UTC.
Kenvue Inc. has a market capitalisation of $34.20B, calculated from the live KVUE share price and shares outstanding.
KVUE trades at a trailing P/E of 20.47, from earnings per share of $0.87 over the last twelve months.
Kenvue Inc. generated revenue of $15.41B over the trailing twelve months, which puts the stock at 2.22 times sales.
KVUE has traded between $14.02 and $20.13 over the past 52 weeks, and the last price is 11.5% below that high.
Yes. Kenvue Inc. keeps 10.76% of revenue as net income over the trailing twelve months.
Wall Street analysts rate KVUE Hold, with an average price target of $19.50, 9.5% above the current price.
Kenvue Inc. is classified under the Consumer Defensive sector and the Household & Personal Products industry, and is domiciled in US.
Kirk L. Perry is the chief executive of Kenvue Inc., which employs 21,890 people.
QFI Terminal shows KVUE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open KVUE in Terminal See plans